Skip to main content

Validation of Hospitalized COVID-19 Diagnosis Detected from Claims-Based Algorithms: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Health Outcome(s)
COVID-19
Description

In this report, we described cohorts identified by five diagnosis code‐based algorithms designed to detect COVID-19 in the inpatient (IP) setting. We calculated the positive predictive value (PPV) and sensitivity of each algorithm to compare algorithm performance, using diagnostic nucleic acid amplification (NAA) test laboratory result as our reference standard. This report describes Phase Two of a two‐phase project.

We distributed this request to six Sentinel Data Partners on October 30, 2020. The study period includes data from February 20, 2020 to October 17, 2020.

Deliverables (1)
Sentinel Modular Program Report: Validation of Hospitalized COVID-19 Diagnosis Detected from Claims-Based Algorithms: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
February 20, 2020 - October 17, 2020
Analysis Type
Site-Specific Query
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Validation of Hospitalized COVID-19 Detected from Claims-Based Algorithms
Manuscript: Validation of Diagnosis Codes to Identify Hospitalized COVID-19 Patients in Health Care Claims Data
Publication: Validation of Claims-based Algorithms to Identify Hospitalized COVID-19 Events within the FDA Sentinel System